Peroxisomal biogenesis disorder is a rare inherited condition that affects how the body breaks down certain fats and supports normal growth and development. Many living with peroxisomal biogenesis disorder are recognized before birth, in infancy, or in early childhood, and the signs can include low muscle tone, feeding problems, hearing or vision loss, seizures, and delays in development. Not everyone will have the same experience. Peroxisomal biogenesis disorder is lifelong, and some forms are very severe in infancy while others are milder and may be diagnosed later in childhood or adulthood. Treatment does not cure peroxisomal biogenesis disorder, but supportive care such as nutrition support, seizure treatment, physical therapy, and hearing or vision care can improve comfort and daily life.
How many people live with Peroxisomal biogenesis disorder?
Peroxisomal biogenesis disorders are a group of very rare inherited conditions; Orphanet classifies them as affecting about 1 to 9 people per 1,000,000, which suggests roughly 8,000 to 74,000 people worldwide (Orphanet, 2024) and about 340 to 3,100 people in the United States if the same range is applied to the U.S. population (Orphanet, 2024). These are broad estimates rather than direct counts, and numbers can differ because some sources report how many people are living with the condition while others report how often it is seen at birth.
Overview
Peroxisomal biogenesis disorderSymptoms
Peroxisomal biogenesis disorder often causes low muscle tone, feeding trouble, hearing or vision loss, and developmental delay. Features can start before birth, at birth, or in early childhood. Some children also have seizures or liver problems.
Outlook and prognosis
Peroxisomal biogenesis disorder often causes lifelong health needs, and outlook depends on the subtype and how severely the brain, liver, hearing, and vision are affected. Some children live only months, while others reach adolescence or adulthood with ongoing specialist care.
Causes and risk factors
Peroxisomal biogenesis disorder is caused by inherited changes in PEX genes, often present from before birth. Risk is highest when both parents carry the same altered gene. Family history and related parents raise the chance; lifestyle does not cause it.
Genetic influences
Genetics are central to peroxisomal biogenesis disorder. It is caused by harmful changes in genes involved in building and running peroxisomes, and the exact gene change often influences how severe symptoms are and when they begin.
Diagnosis
Diagnosis of peroxisomal biogenesis disorder usually starts with clinical features and blood tests. Doctors often confirm it with genetic tests, and sometimes imaging findings such as brain scans help support the diagnosis.
Treatment and drugs
Treatment for peroxisomal biogenesis disorder focuses on day-to-day needs, such as feeding support, seizure medicines, hearing or vision care, and physical therapy. Many living with peroxisomal biogenesis disorder also benefit from regular follow-up with several specialists.
Symptoms
Peroxisomal biogenesis disorder can affect many parts of the body, so day-to-day challenges vary widely. For many people with peroxisomal biogenesis disorder, the earliest concerns involve low muscle tone, feeding trouble, and problems with hearing, vision, or development. The early features of peroxisomal biogenesis disorder can be mild or severe, and some forms are noticed at birth while others become clearer in infancy or childhood.
Many babies with peroxisomal biogenesis disorder feel unusually floppy or weak when held. This can make head control, sitting, walking, breathing, and feeding harder.
Poor sucking, reflux, or trouble swallowing can make feeds take a long time and leave babies tired. Some children gain weight slowly and need extra feeding support to grow well.
Skills such as sitting, talking, walking, and learning often happen later than expected. In peroxisomal biogenesis disorder, the degree of delay can range from mild to severe.
Eyesight may be reduced because parts of the eye do not develop or work normally. Some children are sensitive to light or have trouble tracking faces, toys, or print.
How people usually first notice Peroxisomal biogenesis disorder?
Peroxisomal biogenesis disorder is usually first noticed in infancy, when a baby seems unusually floppy, feeds poorly, has seizures, or is slow to reach early milestones such as holding up the head or making steady eye contact. Doctors and families may also notice hearing or vision problems, an enlarged liver, or physical features present from birth, and in some pregnancies the condition is first suspected on prenatal ultrasound or after newborn testing prompts more evaluation. Because the first signs of peroxisomal biogenesis disorder can vary from one child to another, diagnosis often comes from putting these early clues together with blood tests and genetic testing.
Types of Peroxisomal biogenesis disorder
Peroxisomal biogenesis disorder includes a small group of inherited conditions, and the types of Peroxisomal biogenesis disorder are usually described by the gene involved and by the clinical variant a child develops. Symptoms do not look exactly the same from one family to another, but the main differences are in how early problems begin and how severe they are. In practice, many living with these disorders fall into the Zellweger spectrum or the rhizomelic chondrodysplasia punctata form.
Zellweger syndrome
This is the most severe Zellweger-spectrum variant, with symptoms usually starting at birth or soon after. Babies often have very low muscle tone, feeding trouble, seizures, hearing or vision loss, and liver problems. Development is usually profoundly affected, and medical needs are often urgent from the start.
Neonatal adrenoleukodystrophy
This is an intermediate Zellweger-spectrum variant, so symptoms can be serious but may be less severe than in classic Zellweger syndrome. Children may have low muscle tone, delays in development, hearing or vision problems, and liver disease, with symptoms becoming clearer in infancy. The balance of symptoms can shift over time.
Infantile Refsum disease
This is a milder Zellweger-spectrum variant, and some children are diagnosed later because early signs can be less obvious. Many have developmental delay, hearing or vision loss, poor growth, and liver problems, but they may gain more skills than children with the more severe variants. Not everyone will experience every type of symptom to the same degree.
RCDP type 1
Rhizomelic chondrodysplasia punctata type 1 is a distinct peroxisomal biogenesis disorder linked to a different pattern of growth and bone development. Babies often have marked shortening of the upper arms and thighs, joint stiffness, cataracts, and major developmental challenges. Breathing and feeding difficulties are also common, and severity can vary.
Can I slow down the onset of symptoms?
No. Because peroxisomal biogenesis disorder is an inherited condition that usually starts before birth or early in life, there is no good evidence that diet, exercise, supplements, or other lifestyle changes can meaningfully delay when symptoms begin; these steps may support general health, but they do not prevent the condition. Early and regular care can still help many living with this disorder by finding and treating problems with hearing, vision, feeding, the liver, and development as soon as possible, and research into new treatments is ongoing, so staying connected with a specialist team is still worthwhile.
What genetics can tell you about symptoms
Genetics can tell doctors quite a lot about how peroxisomal biogenesis disorder may show up, because changes in different PEX genes, or different changes within the same gene, can affect how well the body’s peroxisomes work. In general, variants that disrupt this process more severely are linked to symptoms that begin earlier and affect more parts of the body, while less disruptive variants may be associated with milder problems or a later start, although there can still be overlap from one person to another. This means genetic results can help explain why some people have serious brain, liver, vision, and hearing problems in infancy, while others living with the same broad condition may have a slower course with fewer or less severe symptoms.
Causes and risk factors
For most families, the genetic causes of peroxisomal biogenesis disorder are inherited changes in genes that help build peroxisomes, often in a PEX gene. The main risk factor is having two carrier parents, and a family history can raise the chance in future pregnancies. Parents who are blood relatives have a higher chance of carrying the same gene change. The exact gene change is a biological factor that can affect how severe the condition is, and risk can vary widely from person to person. Lifestyle or environmental factors are not known to cause peroxisomal biogenesis disorder, but genetic counseling and testing can help clarify risk.
What are the most common causes or risk factors?
Peroxisomal biogenesis disorder is almost always caused by an inherited gene change that keeps the body from making these tiny cell parts, called peroxisomes, work the right way; most often, a child gets one nonworking copy of the gene from each parent, and the parents are healthy carriers. The main risk factors are a family history of the condition, having a brother or sister with it, or having parents who are related by blood, such as cousins, because they are more likely to carry the same gene change. There are no well-known lifestyle, diet, or environmental causes.
Environmental and biological risk factors
For peroxisomal biogenesis disorder, doctors have not identified clear environmental or non-genetic biological factors that raise the chance of a baby being born with the condition. Unlike some other congenital conditions, there is no well-established link with parental age, routine day-to-day exposures, or common pregnancy health issues. In other words, current evidence does not point to preventable outside causes as risk factors for peroxisomal biogenesis disorder.
No proven link has been found between peroxisomal biogenesis disorder and outside exposures such as air pollution, radiation, or common chemicals. Current medical knowledge does not treat these as established risk factors for the condition.
Older maternal or paternal age is not a known risk factor for peroxisomal biogenesis disorder. This differs from some chromosome conditions, where age can play a clearer role.
Maternal infections, diabetes, or routine pregnancy complications are not recognized as established causes of peroxisomal biogenesis disorder. Doctors do not usually consider these to be confirmed biological risk factors for this condition.
Genetic risk factors
When a baby or child is diagnosed with peroxisomal biogenesis disorder, families often want to know why it happened. The genetic causes of peroxisomal biogenesis disorder are changes in genes that help cells build and maintain peroxisomes, small cell structures needed to process certain fats and support normal development. Most cases are inherited from two healthy carrier parents. The exact gene change can also affect how severe the condition is and when symptoms begin.
PEX genes: Peroxisomal biogenesis disorder is caused by changes in genes that help cells build and run peroxisomes. Most known causes involve PEX genes, including PEX1, PEX6, PEX10, PEX12, PEX26, and PEX7.
Recessive pattern: Most forms follow an autosomal recessive pattern. This means a child usually develops the condition only after inheriting one changed copy of the same gene from each parent.
Carrier parents: Parents with one changed copy are usually healthy and may not know they are carriers. Many people with peroxisomal biogenesis disorder are born to two carrier parents who had no warning signs themselves.
Pregnancy chances: If both parents are carriers of the same gene change, each pregnancy has a 25% chance of an affected child. There is also a 50% chance of a child who is not affected but is still a carrier.
Family history: Having a sibling or close relative with peroxisomal biogenesis disorder can be a clue that the same gene change runs in the family. This is one reason doctors may suggest genetic testing and family counseling.
Related parents: The chance is higher when parents are biologically related, such as cousins, because relatives are more likely to carry the same rare gene change. This does not cause the disorder by itself, but it raises the chance that a child inherits two changed copies.
Lifestyle risk factors
Peroxisomal biogenesis disorder is inherited, so lifestyle habits do not cause it. Still, how lifestyle affects peroxisomal biogenesis disorder can matter for comfort, day-to-day function, and the risk of complications. The most helpful habits are those that support nutrition, mobility, breathing, skin and vision care, and infection prevention while fitting the person’s neurologic and developmental needs.
Feeding difficulties, reflux, or poor growth can worsen weakness and delay recovery in people with peroxisomal biogenesis disorder. Careful meal planning, texture changes, or tube-feeding support may improve energy, hydration, and weight stability.
Some people do better when meals are regular and tailored to swallowing ability, constipation, or liver-related nutrition issues. This is one of the practical lifestyle risk factors for peroxisomal biogenesis disorder because missed intake or poor tolerance can increase fatigue and medical stress.
Gentle, supervised movement can help maintain joint range, reduce stiffness, and support circulation when low muscle tone or spasticity is present. Overexertion or unsafe activity can raise the risk of falls, pain, and loss of function.
Limited mobility, weak cough, or poor coordination can make mucus clearance harder and increase chest infections. Position changes, breathing exercises, and activity within tolerance may help protect lung function.
Risk prevention
Peroxisomal biogenesis disorder is a genetic condition, so there is usually no way to prevent the disorder itself in someone who has inherited it. In practice, prevention focuses on lowering the chance of complications, supporting day-to-day health, and helping families understand future pregnancy risks. Different people need different prevention strategies—there’s no single formula. The exact plan depends on the subtype and how strongly the brain, liver, hearing, vision, and feeding are affected.
For families with a known history of peroxisomal biogenesis disorder, genetic counseling and carrier testing may help clarify the chance of another affected pregnancy. In some cases, this is the main way to reduce the risk of having a child with peroxisomal biogenesis disorder.
Ongoing care with a specialist team can help catch problems early, before they become harder to manage. This often includes checks for growth, development, liver health, hearing, vision, and the early symptoms of peroxisomal biogenesis disorder getting worse.
Many living with peroxisomal biogenesis disorder become sicker more quickly when they get common infections. Keeping up with recommended vaccines, avoiding sick contacts when possible, and getting prompt care for fever or breathing symptoms may lower complications.
Feeding problems and poor weight gain are common in peroxisomal biogenesis disorder, especially in babies and young children. Early feeding support, safe swallowing strategies, and nutrition planning can help reduce dehydration, choking, and undernutrition.
Can you prevent Peroxisomal biogenesis disorder?
Peroxisomal biogenesis disorder usually cannot be prevented, because it is an inherited condition passed down through genes and is not caused by diet, stress, or anything a parent did during pregnancy. If this condition runs in your family, meeting with a genetics specialist before pregnancy and having carrier testing can help you understand your risk and learn about possible family-planning options.
Transmission
For families looking for answers after a diagnosis, it helps to know that Peroxisomal biogenesis disorder is inherited, not caught from someone else. It is not infectious and does not spread through touch, coughing, food, or other everyday contact.
In most families, how Peroxisomal biogenesis disorder is inherited follows an autosomal recessive pattern, which means both parents carry one changed copy of the same gene and usually have no symptoms. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child who inherits neither changed copy.
When to test your genes
Because peroxisomal biogenesis disorders are inherited and usually begin early, genetic testing is most useful when a baby or child has suggestive signs, or when there is a known family history. It can confirm the diagnosis, guide supportive care, and help relatives understand carrier status and future pregnancy risks.
Diagnosis
Peroxisomal biogenesis disorder is usually suspected when a baby or child has a pattern of problems affecting more than one body system, such as low muscle tone, feeding trouble, hearing or vision problems, liver concerns, or delayed development. Getting a diagnosis is often a turning point toward answers and support. Because signs can overlap with other rare conditions, doctors often combine exam findings, lab results, imaging, and genetic tests to confirm the diagnosis of peroxisomal biogenesis disorder.
Doctors look for a recognizable pattern of symptoms and physical findings rather than one single sign. This can include weak muscle tone, seizures, developmental delay, feeding difficulties, hearing or vision loss, and liver enlargement or other organ problems.
Blood and urine tests can look for chemical changes that happen when peroxisomes are not working properly. These results help support the genetic diagnosis of peroxisomal biogenesis disorder and can help rule out some other metabolic conditions.
A genetic test is usually used to confirm the condition by looking for changes in genes linked to peroxisome formation and function. The results can also help clarify the specific type within the disorder spectrum and whether other family members may want testing.
Brain imaging and sometimes liver ultrasound are used to check for changes linked to the disorder and to understand how different organs are affected. These imaging findings do not make the diagnosis on their own, but they can add important supporting evidence.
How is Peroxisomal biogenesis disorder diagnosed?
Doctors usually diagnose peroxisomal biogenesis disorder by putting together a child’s symptoms and exam findings with blood tests that look for a buildup of certain fats and other substances that should be handled by tiny parts of the cell called peroxisomes. They may also do urine tests and check the liver, hearing, vision, and brain to see how the condition is affecting the body. Genetic testing can then help confirm the diagnosis by finding a harmful change in one of the genes linked to the disorder.
Stages of Peroxisomal biogenesis disorder
Peroxisomal biogenesis disorder does not have defined progression stages. This is because it is a group of genetic conditions with a wide range of severity, rather than an illness that follows the same step-by-step course in everyone. Many living with peroxisomal biogenesis disorder are diagnosed based on a mix of symptoms, physical findings, blood tests, urine tests, brain and eye checks, and hearing tests. Early and accurate diagnosis helps you plan ahead with confidence, and doctors also use genetic testing to confirm the diagnosis and help explain the early symptoms of peroxisomal biogenesis disorder.
Outlook and prognosis
Outlook varies widely across the peroxisomal biogenesis disorder spectrum and depends on the specific PEX gene involved, residual peroxisome function, and severity of liver, neurologic, vision, and hearing problems. In the most severe forms, especially classic Zellweger syndrome, prognosis is poor and many affected infants die within the first year of life from respiratory complications, liver failure, or profound neurologic disease. People with intermediate forms such as neonatal adrenoleukodystrophy or infantile Refsum disease may survive into childhood, adolescence, or sometimes adulthood, but often have progressive developmental, sensory, and mobility limitations. Those with milder disease can live much longer, although ongoing medical needs and gradual worsening of hearing loss, visual impairment, ataxia, seizures, or liver involvement are common. There is currently no cure, so prognosis is shaped by supportive multidisciplinary care, early treatment of complications, and the rate at which neurologic and systemic features progress.
Long-term effects
For many living with peroxisomal biogenesis disorder, the long-term picture depends a lot on which body systems are affected and how severe those changes are early in life. Some children have major medical needs from infancy, while others live longer with ongoing vision, hearing, liver, nerve, and developmental challenges. Long-term effects vary widely, even within the same family, and they can change across childhood and adulthood. Thinking about the long-term effects of peroxisomal biogenesis disorder helps set realistic expectations about growth, learning, mobility, and overall health over time.
Many living with peroxisomal biogenesis disorder have lasting delays in speech, movement, and learning. Some need help with daily activities throughout life, while others gain skills more gradually and continue to make progress over time.
Eye problems can worsen over the years and may include reduced sharpness of vision, night blindness, or narrowing side vision. For many, this can mean trouble recognizing faces across a room, moving safely in dim light, or reading standard print.
Hearing loss is common and may be present early or become more noticeable with time. This can affect language development in childhood and make school, conversations, and social situations harder to navigate.
Some people with peroxisomal biogenesis disorder develop ongoing liver problems, including enlargement, scarring, or reduced liver function. In more severe cases, liver disease can affect growth, nutrition, and overall life expectancy.
How is it to live with Peroxisomal biogenesis disorder?
Living with a peroxisomal biogenesis disorder can look very different from one person to the next, but for many it means ongoing medical needs that can affect movement, hearing, vision, feeding, energy, and learning, so daily life often involves therapies, medications, specialist visits, and extra support at home or school. Some people have milder challenges and more independence, while others need hands-on care for much of the day, especially if seizures, liver problems, or developmental differences are part of the picture. For families and other close supporters, this can bring deep love and closeness alongside real emotional, financial, and physical strain, which is why practical support, respite, and a coordinated care team can make such a meaningful difference.
Treatment and drugs
Peroxisomal biogenesis disorder is usually treated by managing the problems it causes, because there is currently no cure that fixes the underlying genetic change. Treatment often looks different for each person, but it may include nutrition support, physical and occupational therapy, hearing and vision care, seizure medicines if needed, and close follow-up for the liver, adrenal glands, and other organs that can be affected. For many people, treatment begins with small daily steps, such as help with feeding, stretching tight muscles, using hearing aids or glasses, and watching for infections or changes in breathing. Support from family or friends can make daily treatment easier, and regular care from a team that may include a pediatrician, neurologist, dietitian, and genetics specialist can help adjust care as symptoms change over time.
Can you cure Peroxisomal biogenesis disorder?
No, there is currently no cure for peroxisomal biogenesis disorder. Treatment focuses on easing symptoms and supporting daily health, which may include help with feeding, medicines for seizures, physical therapy, and care for hearing, vision, breathing, and other body problems, but it cannot fix the underlying genetic cause.
Non-drug treatment
Day-to-day care for people with peroxisomal biogenesis disorder usually focuses on supporting feeding, movement, hearing, vision, and development, since medicines cannot fix the underlying cell problem. Many living with peroxisomal biogenesis disorder need a team approach that changes with age and with how severe symptoms are. Non-drug treatments often lay the foundation for comfort, safety, and the best possible function at home, school, and in the community. Not every approach works the same way, so care is usually tailored to a child’s needs.
Physical therapy can help with low muscle tone, stiffness, balance, and joint tightness. For many, this can mean practicing sitting, standing, walking, and safe transfers in ways that reduce strain and support daily movement.
Occupational therapy focuses on everyday skills such as reaching, grasping, dressing, positioning, and using adaptive equipment. Some strategies can slip naturally into your routine—like seating changes or hand supports that make play, feeding, and school tasks easier.
Speech and language therapy can support communication, including gestures, picture systems, or communication devices when speech is limited. It may also help assess swallowing, which is important when feeding is tiring, slow, or linked to coughing and choking.
Feeding therapy and dietitian support can help with poor weight gain, long mealtimes, reflux, and swallowing trouble. In more severe cases, some may need tube feeding to improve nutrition, hydration, and safety.
Your genes may have an impact on how drugs work for you
For people living with peroxisomal biogenesis disorder, the genetic change causing the condition does not usually help doctors predict how common medicines will work in the way it does for some other health problems. In everyday care, treatment is usually guided more by the symptoms a person has and by how well the liver, kidneys, adrenal glands, and nervous system are working, since these can affect how the body handles medicine. This means medicine choices and doses are often adjusted case by case, especially for seizure medicines and other drugs used to manage day-to-day symptoms.
Pharmacological treatments
Treatment for peroxisomal biogenesis disorder is usually aimed at specific symptoms rather than the root cause, because there is no medicine that corrects the underlying cell problem. The drugs used depend on which body systems are affected, such as seizures, feeding problems, liver disease, muscle stiffness, or adrenal hormone deficiency. Not everyone responds to the same medication in the same way. In practice, many living with peroxisomal biogenesis disorder need a mix of medicines that changes over time.
Seizures are often treated with anti-seizure drugs such as levetiracetam, clobazam, lacosamide, or topiramate. The choice depends on seizure type, age, and liver function, and early symptoms of peroxisomal biogenesis disorder sometimes include difficult-to-control seizures.
If the adrenal glands are not making enough hormones, hydrocortisone is used to replace cortisol and fludrocortisone may be added to replace salt-balancing hormone. These medicines can help with weakness, poor feeding, low blood pressure, or repeated dehydration.
Some people with cholestatic liver disease may be treated with cholic acid or ursodiol to help bile flow and digestion. Doctors may also prescribe vitamin supplements such as vitamins A, D, E, and K, although these are supportive treatments rather than disease-specific drugs.
Feeding discomfort and reflux may be treated with acid-lowering drugs such as omeprazole, lansoprazole, or famotidine. These medicines can reduce pain, vomiting, or arching after feeds, though they do not fix swallowing problems themselves.
Genetic influences
For many families, peroxisomal biogenesis disorder first becomes a genetic question when a baby or child has problems affecting more than one part of the body and doctors start looking for a single underlying cause. Peroxisomal biogenesis disorder is an inherited group of conditions caused by changes in one of several PEX genes, which are needed to build and maintain peroxisomes, tiny parts of cells that help break down certain fats and support the brain, liver, eyes, and other organs. It is usually passed down in an autosomal recessive pattern, meaning a child must inherit a nonworking copy of the gene from both parents; a carrier means you hold the gene change but may not show symptoms. This is why parents are often healthy and may have no clear family history before an affected child is born. The exact gene involved can affect how severe the condition is, so the genetic causes of peroxisomal biogenesis disorder can lead to a wide range of illness, from very serious disease in infancy to milder forms found later in childhood or adulthood. Genetic testing can confirm the diagnosis and help families understand the chance of it happening again in a future pregnancy.
Is Peroxisomal biogenesis disorder genetic?
Genetics are central to peroxisomal biogenesis disorder. It is caused by harmful changes in genes involved in building and running peroxisomes, and the exact gene change often influences how severe symptoms are and when they begin.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal part of being human and are common in the wider population. Most do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a variant tied to a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-understood variant in one specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Care often looks different from one family to another, because the gene change behind peroxisomal biogenesis disorder can strongly affect which symptoms appear and how severe they become. Not every difference in response is genetic, but in peroxisomal biogenesis disorder, the exact genetic finding can help explain why one person needs more treatment for seizures, feeding problems, vision or hearing changes, or hormone issues than another. At this time, there is no medicine that fixes the underlying cell problem in most people with this condition, so doctors usually treat the specific problems causing day-to-day symptoms. If the disorder has affected the liver or other organs, some medicines may need to be chosen more carefully and doses may need closer follow-up. Genetic test results can also help confirm the diagnosis, guide monitoring, and show whether someone may qualify for research studies or future targeted treatments. In practice, the best treatment for peroxisomal biogenesis disorder is usually a personalized plan based on symptoms, age, organ involvement, and the specific gene change.
Interactions with other conditions
People living with peroxisomal biogenesis disorder often have health problems in several body systems at once, so symptoms can overlap rather than appearing as one single issue. This means liver disease, hearing loss, vision problems, seizures, feeding difficulties, and developmental delays may affect each other and make day-to-day care more complex. Doctors call it a comorbidity when two conditions occur together, and in peroxisomal biogenesis disorder this can shape how symptoms show up and how treatment is planned. For example, if someone has both muscle weakness and hearing or vision loss, communication and mobility can become harder than either problem alone would suggest. Breathing issues, infections, or swallowing problems may also have a bigger effect in people with peroxisomal biogenesis disorder because the body is already coping with a multisystem condition. Interactions can look very different from person to person, so care usually works best when specialists coordinate closely and watch how one problem may change the others over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Peroxisomal biogenesis disorder?
Other conditions that can look similar to peroxisomal biogenesis disorder include mitochondrial diseases, some inherited brain white matter disorders such as X-linked adrenoleukodystrophy, and certain lysosomal storage diseases, which are rare illnesses where harmful substances build up in the body. In babies and young children, doctors may also consider congenital infections, cerebral palsy, or severe muscle and nerve disorders because these can also cause low muscle tone, feeding problems, seizures, vision or hearing changes, and delayed development. Because the symptoms overlap so much, blood tests, brain scans, hearing and vision checks, and genetic testing are often needed to tell them apart.
History
Doctors first recognized the most severe forms of peroxisomal biogenesis disorder in babies who were very unwell soon after birth. These infants often had trouble feeding, low muscle tone, seizures, and problems affecting more than one organ, so early reports focused on the sickest children. For families, this often meant a long search for answers at a time when testing was limited and many rare disorders looked similar.
As medical science evolved, doctors began to see that peroxisomal biogenesis disorder was not just one single picture. Some children had severe symptoms in the newborn period, while others had milder or more slowly developing problems with hearing, vision, growth, movement, or learning. Conditions that were once described separately were later understood to be part of the same spectrum, which helped explain why the early symptoms of peroxisomal biogenesis disorder can vary so much from one person to another.
By the late 20th century, laboratory testing made a major difference. Researchers could measure certain fats and other substances in blood and tissues, showing that these disorders were linked to problems in tiny parts of cells called peroxisomes, which help break down and process certain molecules. That shift moved the field from describing symptoms alone to understanding the underlying cell problem.
In recent decades, awareness has grown as brain imaging, biochemical testing, and broader genetic testing have made diagnosis more accurate. This has also helped doctors recognize milder cases that might once have been missed or given a different label. Today, the history of peroxisomal biogenesis disorder is still unfolding, but it is much clearer than it was in the past, and that better understanding can help families get more accurate information, support, and care.